Welcome to the new version of CaltechAUTHORS. Login is currently restricted to library staff. If you notice any issues, please email coda@library.caltech.edu
Published June 2022 | Supplemental Material + Published
Journal Article Open

Reconstruction of a large-scale outbreak of SARS-CoV-2 infection in Iceland informs vaccination strategies

Abstract

Objectives: The spread of SARS-CoV-2 is dependent on several factors, both biological and behavioural. The effectiveness of nonpharmaceutical interventions can be attributed largely to changes in human behaviour, but quantifying this effect remains challenging. Reconstructing the transmission tree of the third wave of SARS-CoV-2 infections in Iceland using contact tracing and viral sequence data from 2522 cases enables us to directly compare the infectiousness of distinct groups of persons. Methods: The transmission tree enables us to model the effect that a given population prevalence of vaccination would have had on the third wave had one of three different vaccination strategies been implemented before that time. This allows us to compare the effectiveness of the strategies in terms of minimizing the number of cases, deaths, critical cases, and severe cases. Results: We found that people diagnosed outside of quarantine (Ȓ = 1.31) were 89% more infectious than those diagnosed while in quarantine (Ȓ = 0.70) and that infectiousness decreased as a function of time spent in quarantine before diagnosis, with people diagnosed outside of quarantine being 144% more infectious than those diagnosed after ≥3 days in quarantine (Ȓ = 0.54). People of working age, 16 to 66 years (Ȓ = 1.08), were 46% more infectious than those outside of that age range (Ȓ = 0.74). Discussion: We found that vaccinating the population in order of ascending age or uniformly at random would have prevented more infections per vaccination than vaccinating in order of descending age, without significantly affecting the expected number of deaths, critical cases, or severe cases.

Additional Information

© 2022 European Society of Clinical Microbiology and Infectious Diseases. Published by Elsevier Ltd. All rights reserved. Received 29 June 2021, Revised 19 January 2022, Accepted 5 February 2022, Available online 17 February 2022. Author contributions: K.E.H. and S.R. contributed equally to this article. KEH, SR, PM, and KS designed the study and interpreted the results. ABA, MA, KB, GH, AdJ, AsJ, NK, BK, DNM, LLR, GMS, AS, FJ, OTM, GLN, and JS planned and performed the laboratory work. ESE, RP, MIS, and MT performed the data collection. KEH, SR, HJ, ESE, RF, GG, KRG, AG, BOJ, KSJ, TK, RP, MIS, GS, EAT, BT, MT, AH, HH, IJ, GM, PS, UT, and PM performed the data curation. KEH, SR, HJ, OE, DFG, and PM performed the statistical and bioinformatics analyses. KEH, SR, PM, and KS drafted the manuscript. All authors contributed to the final version of the paper. Ethics statement: This study was approved by the National Bioethics Committee of Iceland (approval no. VSN-20-070) after review by the Icelandic Data Protection Authority. Consent was not required from the participants in the study. Transparency declaration: All authors declare no conflicts of interest. No external funding.

Attached Files

Published - main.pdf

Supplemental Material - 1-s2.0-S1198743X22000854-mmc1.docx

Files

main.pdf
Files (3.1 MB)
Name Size Download all
md5:fcb89db27ee0e439b4f0e1d815d16a9e
1.6 MB Preview Download
md5:9ab3b9cd354e55ac5e0e329f51f32ee3
1.5 MB Download

Additional details

Created:
August 22, 2023
Modified:
October 23, 2023